Bladder EpiCheck it a sensitive, specific test to analyze subtle, disease-specific changes across 15 methylation markers associated with bladder cancer.
The insulin delivery device was designed to serve the more than 3M people using basal insulin or transitioning to insulin therapy to treat their type 2 diabetes